Home
/
Programs
/
Empagliflozin (Jardiance) Update: Expanding Indications and Evidence Across T2DM, CKD, and Heart Failure
Empagliflozin (Jardiance) Update: Expanding Indications and Evidence Across T2DM, CKD, and Heart Failure
Educational Activities (EA)
60.0
Reviewing Performance (RP)
Measuring Outcomes (MO)
Brief Overview
This session provides an evidence-based update on the expanding role of Empagliflozin (Jardiance) in managing Type 2 Diabetes (T2DM), chronic kidney disease (CKD), and Heart Failure (HF). It reviews the latest clinical data supporting its cardiometabolic and renal benefits, along with details of the new PBS expansion effective April 2025, listing SGLT2 inhibitors for all three indications. Delivered by an endocrinologist, the program helps clinicians stay informed on updated prescribing criteria and practical strategies to optimise patient outcomes across multiple chronic conditions.
Program Details
- PBS eligibility
- TGA approved indications
- long term & short term data on quality & quality of life
- in clinic specialist meetings
Program Outcome
T2DM, CKD & HF education regarding the use of Jardiance run these patients.
- PBS eligibility
- CV data
- Long term outcomes data
- TGA approved indications
- Differences between SGLT2 medications
1 Hrs 0 Mins
- open and collaborative approach
- use case studies
- long term & short term data on quality & quality of life
- eAID slide shows with data’s and leave behind literatures
in person follow up with their learnings and emails follow-ups
Core Medical Practice Values
Our program address the need of diverse populations by implementations culturally competent practices through staff training, inclusive policies ad community engagement.
Our program explores the causes of health disparities by analysing social detriments of health and utilising data-driven approach.
Our program always aligns with the knowledge of the participants and comply with Australian Professional Standards and Codes of Conduct
Our program always seeks to agrees the best possible ethical decision making
Topics Covered
Addiction Medicine
---
Anaesthetics
---
Blog Category
---
Cardiology and Vascular
---
Dentistry
---
Dermatology
---
Diagnostics and Pathology
---
Ear Nose and Throat (ENT)
---
Endocrinology
---
Events
---
FAQs Section
---
Gastroenterology and Hepatology
---
General Surgery
---
Genetic
---
Geriatrician
---
Gynaecology and Obstetric
---
Haematology
---
Immunology and Allergy
---
Master
---
Nephrology
---
Neurology and Neurosurgery
---
Oncology
---
Ophthalmology
---
Orthopedics
---
Paediatric
---
Plastic and Cosmetic Surgery
---
Program Category
---
Program Type
---
Psychiatry
---
Radiology
---
Rehabilitation Medicine
---
Respiratory
---
Rheumatology
---
Sexual and Reproductive Health
---
Urological Services
---
Topic
---
Delivery Method & Format
0 Hours total Duration
In Person
Interactive Learning: Workshop, Case-based Discussion (focuses on active participation and applying knowledge)
CPD Home (Accreditor)
Suited for
Practice Nurses, Practitioners, Practice Managers
AUS
can